1. Home
  2. LMFA vs BOLT Comparison

LMFA vs BOLT Comparison

Compare LMFA & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.49

Market Cap

10.6M

Sector

Finance

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$5.90

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
BOLT
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.5M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
LMFA
BOLT
Price
$0.49
$5.90
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$5.00
$34.00
AVG Volume (30 Days)
487.8K
31.3K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,567,508.00
$5,195,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$4.41
52 Week High
$5.14
$12.60

Technical Indicators

Market Signals
Indicator
LMFA
BOLT
Relative Strength Index (RSI) 32.97 61.61
Support Level $0.43 $5.50
Resistance Level $0.59 $5.71
Average True Range (ATR) 0.06 0.33
MACD 0.01 0.05
Stochastic Oscillator 18.53 84.34

Price Performance

Historical Comparison
LMFA
BOLT

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: